Over-Prescription Of Drugs - Cause Of Concern For UK Government Health Officials

by Rishika Gupta on December 9, 2018 at 11:00 AM
Over-Prescription Of Drugs - Cause Of Concern For UK Government Health Officials

The British Health Secretary Matt Hancock has called a review to end "polypharmacy." As during a survey it was found that nearly half of those over 75-year-olds were taking five or more medicines.

The review will look at patients most at risk of suffering from adverse effects from overprescribing of tablets and pills, Xinhua news agency reported.


Spending on medicines by the National Health Service (NHS) in England has grown from $16.55 billion in 2010-2011 to over $23 billion in 2017-2018, an average growth of around 5 percent .

It now means 1.1 billion prescriptions for medicines are dispensed every year by family doctors, known as GPs.

Chief Pharmaceutical Officer Dr. Keith Ridge will lead the review into medicine use. He will look at addressing "problematic polypharmacy" where patients take multiple medicines unnecessarily, the report said.

Ridge said recent successes by NHS England to reduce unnecessary antibiotics and medicines in care homes and family doctor surgeries, known as polypharmacy, are beginning to end overmedication for people with learning disabilities, showing what can be done on what is an important topic.

The review will consider individual circumstances where patients may be most at risk of suffering from adverse effects from overprescribing.

The overprescribing of medicines can be dangerous for older people who often take a cocktail of different medicines to manage complex health conditions, said health officials.

They may suffer side effects of their medicine regimes that lead to them falling and being admitted to hospital. Some patients remain for years on repeat prescriptions which roll over without ever being reviewed by doctors.

The British Health Secretary said: "Poorly managed prescribing can lead to serious issues for patients such as increased admissions to hospital or antibiotic resistance.

"As we invest an extra 20.5 billion pounds ($26.1 billion) a year into our NHS we want to empower doctors and pharmacists to use the data available to ensure patients get the medicines they need and stop taking those that no longer benefit them."

The survey will also look at the role of digital technologies in reducing overprescribing as well as increasing other forms of care, including social prescribing.

Source: IANS
Font : A-A+



Recommended Readings

Latest Drug News

Can a Needle-Free Patch Transform Zika Protection?
Researchers create needle-free Zika vaccine patch, using HD-MAP tech, aiming to protect against fatal virus spread by mosquitoes.
Prolonging Market Exclusivity of Brand-name Insulin
Examining FDA and patent records, researchers found that insulin manufacturers prolong market exclusivity for brand-name products.
FDA Boosts Orphan Drug Designations for Myelofibrosis Treatments
The rise in FDA ODD awards indicates a collective endeavor to create new myelofibrosis medications devoid of mechanisms inducing anemia.
Anti-Rheumatic Drugs May Help Prevent Thyroid Disease
The most significant decrease in autoimmune thyroid disease risk was observed in rheumatoid arthritis patients receiving immunomodulatory drugs or 'biological DMARDs'.
Apotransferrin's Potential in Early Stroke Therapy Revealed
Human apotransferrin injected to mice models suffering from intracerebral hemorrhage was found to mitigate the serious effects of stroke.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Over-Prescription Of Drugs - Cause Of Concern For UK Government Health Officials Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests